At residual stage of stroke 64 patients with different forms of aphasia were administered intranasally subendocrine doses of 1-desamino-8-D-argininvasopressin (adiuretin-SD). It was established that peptide activates expressive and impressive speech of patients. Improvement of speech occurred in 79% of cases.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[the clinical
4
clinical evaluation
4
evaluation vasopressin
4
vasopressin treatment
4
treatment aphasias]
4
aphasias] residual
4
residual stage
4
stage stroke
4
stroke patients
4
patients forms
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!